Skip to main content

George Charles Hughes IV, MD

Associate Professor of Surgery
Office: 3580 White Zone, Duke South, Durham, NC 27710
Campus Mail: DUMC Box 3051 Med Ctr, Durham, NC 27710

Education and Training

  • M.D., Duke University, 1995

Selected Grants

Publications

Reardon, Michael J., Neal S. Kleiman, David H. Adams, Steven J. Yakubov, Joseph S. Coselli, G Michael Deeb, Daniel O’Hair, et al. “Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.” Jama Cardiol 1, no. 8 (November 1, 2016): 945–49. https://doi.org/10.1001/jamacardio.2016.2257.

Full Text

Popma, Jeffrey, George Dibu, G Chad Hughes, Susheel Kodali, Isaac George, Jae Oh, James Slater, and Mathew Williams. “TCT-37 Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results from the Evolut R US Pivotal Study.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B16. https://doi.org/10.1016/j.jacc.2016.09.174.

Full Text

Gleason, Thomas, Jeffrey Popma, Michael Reardon, John Schindler, Robert Hagberg, G Michael Deeb, David Adams, John Conte, Trip Zorn, and G Chad Hughes. “TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B152. https://doi.org/10.1016/j.jacc.2016.09.505.

Full Text

Sherwood, Matthew, Qun Xiang, Roland Matsouaka, G Chad Hughes, Sreekanth Vemulapalli, Amit Vora, Eric Peterson, and Sunil Rao. “TCT-78 Incidence and Outcomes of Vascular Complications and Bleeding Events in Patients undergoing TAVR in contemporary U.S. practice: Insights from the STS/ACC TVT Registry®.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B32. https://doi.org/10.1016/j.jacc.2016.09.226.

Full Text

Gleason, Thomas G., John T. Schindler, David H. Adams, Michael J. Reardon, Neal S. Kleiman, Louis R. Caplan, John V. Conte, et al. “The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.” J Thorac Cardiovasc Surg 152, no. 1 (July 2016): 85–96. https://doi.org/10.1016/j.jtcvs.2016.02.073.

Full Text

Deeb, G Michael, Michael J. Reardon, Stan Chetcuti, Himanshu J. Patel, P Michael Grossman, Steven J. Yakubov, Neal S. Kleiman, et al. “3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.” J Am Coll Cardiol 67, no. 22 (June 7, 2016): 2565–74. https://doi.org/10.1016/j.jacc.2016.03.506.

Full Text

Andersen, Nicholas D., Ehsan Benrashid, Adia K. Ross, Lisa C. Pickett, Peter K. Smith, Mani A. Daneshmand, Jacob N. Schroder, Jeffrey G. Gaca, and G Chad Hughes. “The utility of the aortic dissection team: outcomes and insights after a decade of experience.” Ann Cardiothorac Surg 5, no. 3 (May 2016): 194–201. https://doi.org/10.21037/acs.2016.05.12.

Full Text

Pages